Article info

Short report
Safety of breast feeding during rituximab treatment in multiple sclerosis

Authors

  • Brit Ellen Rød Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, NorwayDepartment of Clinical Medicine, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Øivind Torkildsen Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, NorwayDepartment of Clinical Medicine, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Kjell-Morten Myhr Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, NorwayDepartment of Clinical Medicine, University of Bergen, Bergen, Norway PubMed articlesGoogle scholar articles
  • Lars Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, NorwayNorwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital, Bergen, Norway PubMed articlesGoogle scholar articles
  • Stig Wergeland Department of Clinical Medicine, University of Bergen, Bergen, NorwayNorwegian MS-Registry and Biobank, Haukeland University Hospital, Bergen, Norway PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Stig Wergeland, Norwegian MS-registry and biobank, Haukeland University Hospital, Bergen 5021, Norway; stig.wergeland{at}helse-bergen.no
View Full Text

Citation

Rød BE, Torkildsen Ø, Myhr K, et al
Safety of breast feeding during rituximab treatment in multiple sclerosis

Publication history

  • Received May 4, 2022
  • Accepted June 29, 2022
  • First published July 25, 2022.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.